Bright Minds Biosciences Inc (NASDAQ:DRUG) currently has a daily average trading volume of 2.87M but it saw 1160889 shares traded in last market. With a market cap of 220.77M USD, the company’s current market price of $49.50 came rising about 5.32 while comparing to the previous closing price of $47.00. In past 52 weeks, the stock remained buoying in the range of price level as high as $79.02 and as low as $0.93. In the recent trading on the day, stock has struck highest price mark of $45.51 while lowest mark touched by it was $53.0692.
Taking a look at 20-day trading activity of Bright Minds Biosciences Inc (DRUG) gives us an average price of $17.13, while its current price level is -37.36% below from 52-week high level whereas it is 5222.58% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $7.55 while that of 200 days or SMA-200 reads an average of $2.90. A closer look into the stock’s movement over the week reveals that its volatility is standing at 48.26% during that period while stretching the period over a month that increases to 96.94%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 78.53 which implies that the stock is in overbought territory.
Over the week, DRUG’s stock price is moving 128.11% up while it is 4078.27% when we observe its performance for the past one month. Year-to-date it is 3361.54% up and over the past year, the stock is showing an upside performance of 3486.96%.
Currently, Bright Minds Biosciences Inc’s total number of outstanding shares is 3.77M. Company’s return on investment (ROI) stands at -59.08% and return on equity (ROE) at -51.16%. Stock’s beta reads -0.35. Stock has a price to book (P/B) ratio of 49.57. Its return on asset (ROA) is -47.96% on average.
